Probiotics can treat hepatic encephalopathy

Area of Science:

• Hepatology
• Gastroenterology
• Microbiome Research

Background:

• Hepatic encephalopathy (HE) is a frequent and serious complication of liver disease, impacting daily life.
• The precise mechanisms driving HE remain unclear, but gut microbiota metabolites are key factors.
• Current treatments like lactulose and antibiotics have limitations, including side effects and cost.

Purpose of the Study:

• To explore the potential of probiotics as a novel therapeutic strategy for hepatic encephalopathy.
• To evaluate how probiotics might interfere with the pathological processes of HE.

Main Methods:

• This study reviews the known mechanisms of HE pathogenesis.
• It examines the potential of probiotics, defined as live microorganisms conferring health benefits.
• Mechanisms by which probiotics could impact HE are discussed.

Main Results:

• Probiotics possess diverse mechanisms of action relevant to HE.
• These mechanisms suggest a potential to disrupt HE pathogenesis.

Conclusions:

• Probiotics represent a promising alternative for managing hepatic encephalopathy.
• They may offer advantages over traditional treatments due to their potential to address underlying mechanisms.